Serum CTRP3 Level is Associated with Osteoporosis in Postmenopausal Women^[*]

Abstract

Background As a novel adipokine, CTRP3 involves in various functions of energy metabolism. Recent advance reveals a complex interaction between bone and adipose tissue via the secretion of adipokines.

Aims A hospital-based case-control study was conducted to investigate the role of serum CTRP3 in osteoporosis among postmenopausal women.

Methods Serum levels of CTRP3 and osteocalcin were measured. Bone mineral density (BMD) was obtained on femoral neck and lumbar spines by dual energy X-ray absorptiometry.

Results Serum CTRP3 level was lower in subjects with osteoporosis (76.7±22.1 ng/ml) than it in controls (89.4±22.5 ng/ml) (P<0.001). Meanwhile, the frequency of osteoporosis presented a significant decrease (66.4%, 53.9% and 35.9%, P<0.001), in the tertiles of serum CTRP3. Furthermore, serum CTRP3 witnessed an association with a lower risk of osteoporosis (adjusted odds ratio=0.973, 95% confidence interval [0.963–0.983], P<0.001). Lastly, serum CTRP3 level was positively correlated with femoral BMD (r=0.403, P<0.001), lumbar BMD (r=0.368, P<0.001), and HDL-C (r=0.118, P=0.022), among all participants after adjustment. Meanwhile, CTRP3 presented negative correlations with HOMA-IR (r=−0.136, P=0.008) and insulin (r=−0.192, P <0.001).

Conclusions It shows that a decreased serum level of CTRP3 was independently associated with osteoporosis.

Key words

CTRP3 - osteoporosis - bone mineral density - adipokine

^* This hospital-based case-control study showed that a decreased serum level of CTRP3, a novel adipokine involves in various functions of energy metabolism, was independently associated with osteoporosis in postmenopausal women.

• References

• 1 Scherer PE. Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes 2006; 55: 1537-1545
• 2 Rosen ED, Spiegelman BM. Adipocytes as regulators of energy balance and glucose homeostasis. Nature 2006; 444: 847-853
• 3 Zhang Y, Proenca R, Maffei M. et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-432
• 4 Wong GW, Wang J, Hug C. et al. A family of Acrp30/adiponectin structural and functional paralogs. Proceedings of the National Academy of Sciences of the United States of America 2004; 101: 10302-10307
• 5 Shapiro L, Scherer PE. The crystal structure of a complement-1q family protein suggests an evolutionary link to tumor necrosis factor. Current Biology: CB 1998; 8: 335-338
• 6 Maeda T, Abe M, Kurisu K. et al. Molecular cloning and characterization of a novel gene, CORS26, encoding a putative secretory protein and its possible involvement in skeletal development. The Journal of Biological Chemistry 2001; 276: 3628-3634
• 7 Maeda T, Jikko A, Abe M. et al. Cartducin, a paralog of Acrp30/adiponectin, is induced during chondrogenic differentiation and promotes proliferation of chondrogenic precursors and chondrocytes. Journal of Cellular Physiology 2006; 206: 537-544
• 8 Wolfing B, Buechler C, Weigert J. et al. Effects of the new C1q/TNF-related protein (CTRP-3) "cartonectin" on the adipocytic secretion of adipokines. Obesity 2008; 16: 1481-1486
• 9 Peterson JM, Seldin MM, Wei Z. et al. CTRP3 attenuates diet-induced hepatic steatosis by regulating triglyceride metabolism. American journal of physiology Gastrointestinal and Liver Physiology 2013; 305: G214-224
• 10 Peterson JM, Wei Z, Wong GW. C1q/TNF-related protein-3 (CTRP3), a novel adipokine that regulates hepatic glucose output. The Journal of Biological Chemistry 2010; 285: 39691-39701
• 11 Wong GW, Krawczyk SA, Kitidis-Mitrokostas C. et al. Molecular, biochemical and functional characterizations of C1q/TNF family members: adipose-tissue-selective expression patterns, regulation by PPAR-gamma agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functions. The Biochemical journal 2008; 416: 161-177
• 12 Yang Y, Li Y, Ma Z. et al. A brief glimpse at CTRP3 and CTRP9 in lipid metabolism and cardiovascular protection. Progress in lipid research 2016; 64: 170-177
• 13 Li Y, Wright GL, Peterson JM. C1q/TNF-Related Protein 3 (CTRP3) Function and Regulation. Comprehensive Physiology 2017; 7: 863-878
• 14 Wolf RM, Steele KE, Peterson LA. et al. Lower Circulating C1q/TNF-Related Protein-3 (CTRP3) levels are associated with obesity: A Cross-Sectional Study. PloS One 2015; 10: e0133955
• 15 Deng W, Li C, Zhang Y. et al. Serum C1q/TNF-related protein-3 (CTRP3) levels are decreased in obesity and hypertension and are negatively correlated with parameters of insulin resistance. Diabetology & metabolic syndrome 2015; 7: 33
• 16 Ban B, Bai B, Zhang M. et al. Low serum cartonectin/CTRP3 concentrations in newly diagnosed type 2 diabetes mellitus: in vivo regulation of cartonectin by glucose. PloS One 2014; 9: e112931
• 17 Tan BK, Chen J, Hu J. et al. Metformin increases the novel adipokine cartonectin/CTRP3 in women with polycystic ovary syndrome. The Journal of clinical endocrinology and metabolism 2013; 98: E1891-1900
• 18 Li M, Xu Y, Xu M. et al. Association between nonalcoholic fatty liver disease (NAFLD) and osteoporotic fracture in middle-aged and elderly Chinese. The Journal of Clinical Endocrinology and Metabolism 2012; 97: 2033-2038
• 19 Pirgon O, Bilgin H, Tolu I. et al. Correlation of insulin sensitivity with bone mineral status in obese adolescents with nonalcoholic fatty liver disease. Clinical Endocrinology 2011; 75: 189-195
• 20 Pardee PE, Dunn W, Schwimmer JB. Non-alcoholic fatty liver disease is associated with low bone mineral density in obese children. Alimentary Pharmacology & Therapeutics 2012; 35: 248-254
• 21 Confavreux CB. Bone: from a reservoir of minerals to a regulator of energy metabolism. Kidney International 2011; 79121: S14-19
• 22 Musso G, Paschetta E, Gambino R. et al. Interactions among bone, liver, and adipose tissue predisposing to diabesity and fatty liver. Trends in Molecular Medicine 2013; 19: 522-535
• 23 Zhu J, Wan X, Wang Y. et al. Serum fetuin B level increased in subjects of nonalcoholic fatty liver disease: A case-control study. Endocrine 2017; 56: 208-211
• 24 Zhu JZ, Zhu HT, Dai YN. et al. Serum periostin is a potential biomarker for non-alcoholic fatty liver disease: A case-control study. Endocrine 2016; 51: 91-100
• 25 He J, Li JC, Xie H. et al. Serum Chemerin Levels in relation to Osteoporosis and Bone Mineral Density: A Case-Control Study. Disease Markers 2015; 2015: 786708
• 26 Faul F, Erdfelder E, Buchner A. et al. Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behavior Research Methods 2009; 41: 1149-1160
• 27 Kim JY, Min JY, Baek JM. et al. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo. Bone 2015; 79: 242-251
• 28 Yokohama-Tamaki T, Maeda T, Tanaka TS. et al. Functional analysis of CTRP3/cartducin in Meckel's cartilage and developing condylar cartilage in the fetal mouse mandible. Journal of Anatomy 2011; 218: 517-533